Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study

Affiliations

• ¹ Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
• ² Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44114, USA.
• ³ Clinical Infectious Diseases, Department of System Medicine, University of Rome Tor Vergata, Rome, Italy.
• ⁴ Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy.
• ⁵ Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Aviano, Italy.
• ⁶ Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. [email protected].
• ⁷ Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy. [email protected].